Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors

Author:

Nakazawa TsutomuORCID,Morimoto Takayuki,Maeoka Ryosuke,Matsuda Ryosuke,Nakamura MitsutoshiORCID,Nishimura Fumihiko,Yamada Shuichi,Nakagawa Ichiro,Park Young-SooORCID,Nakase Hiroyuki,Tsujimura Takahiro

Publisher

Elsevier BV

Subject

Developmental Biology,Biomedical Engineering,Biomaterials

Reference46 articles.

1. Japan's challenges of translational regenerative medicine: act on the safety of regenerative medicine;Tobita;Regen Ther,2016

2. CAR T cells in solid tumors: challenges and opportunities;Marofi;Stem Cell Res Ther,2021

3. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma;O'Rourke;Sci Transl Med,2017

4. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia;Davila;Sci Transl Med,2014

5. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3